Controlled Bioactive Delivery Using Degradable Electroactive Polymers

Biomaterials capable of precisely controlling the delivery of agrochemicals/biologics/drugs/fragrances have significant markets in the agriscience/healthcare industries. Here, we report the development of degradable electroactive polymers and their application for the controlled delivery of a clinic...

Full description

Saved in:
Bibliographic Details
Published inBiomacromolecules Vol. 23; no. 7; pp. 3031 - 3040
Main Authors Ashton, Mark D., Cooper, Patricia A., Municoy, Sofia, Desimone, Martin F., Cheneler, David, Shnyder, Steven D., Hardy, John G.
Format Journal Article
LanguageEnglish
Published American Chemical Society 11.07.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Biomaterials capable of precisely controlling the delivery of agrochemicals/biologics/drugs/fragrances have significant markets in the agriscience/healthcare industries. Here, we report the development of degradable electroactive polymers and their application for the controlled delivery of a clinically relevant drug (the anti-inflammatory dexamethasone phosphate, DMP). Electroactive copolymers composed of blocks of polycaprolactone (PCL) and naturally occurring electroactive pyrrole oligomers (e.g., bilirubin, biliverdin, and hemin) were prepared and solution-processed to produce films (optionally doped with DMP). A combination of in silico/in vitro/in vivo studies demonstrated the cytocompatibility of the polymers. The release of DMP in response to the application of an electrical stimulus was observed to be enhanced by ca. 10–30% relative to the passive release from nonstimulated samples in vitro. Such stimuli-responsive biomaterials have the potential for integration devices capable of delivering a variety of molecules for technical/medical applications.
AbstractList Biomaterials capable of precisely controlling the delivery of agrochemicals/biologics/drugs/fragrances have significant markets in the agriscience/healthcare industries. Here, we report the development of degradable electroactive polymers and their application for the controlled delivery of a clinically relevant drug (the anti-inflammatory dexamethasone phosphate, DMP). Electroactive copolymers composed of blocks of polycaprolactone (PCL) and naturally occurring electroactive pyrrole oligomers (e.g., bilirubin, biliverdin, and hemin) were prepared and solution-processed to produce films (optionally doped with DMP). A combination of in silico/in vitro/in vivo studies demonstrated the cytocompatibility of the polymers. The release of DMP in response to the application of an electrical stimulus was observed to be enhanced by ca. 10–30% relative to the passive release from nonstimulated samples in vitro. Such stimuli-responsive biomaterials have the potential for integration devices capable of delivering a variety of molecules for technical/medical applications.
Biomaterials capable of precisely controlling the delivery of agrochemicals/biologics/drugs/fragrances have significant markets in the agriscience/healthcare industries. Here, we report the development of degradable electroactive polymers and their application for the controlled delivery of a clinically relevant drug (the anti-inflammatory dexamethasone phosphate, DMP). Electroactive copolymers composed of blocks of polycaprolactone (PCL) and naturally occurring electroactive pyrrole oligomers (e.g., bilirubin, biliverdin, and hemin) were prepared and solution-processed to produce films (optionally doped with DMP). A combination of in silico/in vitro/in vivo studies demonstrated the cytocompatibility of the polymers. The release of DMP in response to the application of an electrical stimulus was observed to be enhanced by ca. 10-30% relative to the passive release from nonstimulated samples in vitro. Such stimuli-responsive biomaterials have the potential for integration devices capable of delivering a variety of molecules for technical/medical applications.Biomaterials capable of precisely controlling the delivery of agrochemicals/biologics/drugs/fragrances have significant markets in the agriscience/healthcare industries. Here, we report the development of degradable electroactive polymers and their application for the controlled delivery of a clinically relevant drug (the anti-inflammatory dexamethasone phosphate, DMP). Electroactive copolymers composed of blocks of polycaprolactone (PCL) and naturally occurring electroactive pyrrole oligomers (e.g., bilirubin, biliverdin, and hemin) were prepared and solution-processed to produce films (optionally doped with DMP). A combination of in silico/in vitro/in vivo studies demonstrated the cytocompatibility of the polymers. The release of DMP in response to the application of an electrical stimulus was observed to be enhanced by ca. 10-30% relative to the passive release from nonstimulated samples in vitro. Such stimuli-responsive biomaterials have the potential for integration devices capable of delivering a variety of molecules for technical/medical applications.
Biomaterials capable of precisely controlling the delivery of agrochemicals/biologics/drugs/fragrances have significant markets in the agriscience/healthcare industries. Here, we report the development of degradable electroactive polymers and their application for the controlled delivery of a clinically relevant drug (the anti-inflammatory dexamethasone phosphate, DMP). Electroactive copolymers composed of blocks of polycaprolactone (PCL) and naturally occurring electroactive pyrrole oligomers (e.g., bilirubin, biliverdin, and hemin) were prepared and solution-processed to produce films (optionally doped with DMP). A combination of in silico/in vitro/in vivo studies demonstrated the cytocompatibility of the polymers. The release of DMP in response to the application of an electrical stimulus was observed to be enhanced by ca. 10–30% relative to the passive release from nonstimulated samples in vitro. Such stimuli-responsive biomaterials have the potential for integration devices capable of delivering a variety of molecules for technical/medical applications.
Author Ashton, Mark D.
Shnyder, Steven D.
Hardy, John G.
Municoy, Sofia
Desimone, Martin F.
Cooper, Patricia A.
Cheneler, David
AuthorAffiliation Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), Facultad de Farmacia y Bioquímica, Consejo Nacional de Investigaciones, Científicas y Técnicas (CONICET)
Department of Engineering, Faculty of Science and Technology
Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences
Materials Science Institute
Department of Chemistry, Faculty of Science and Technology
Lancaster University
AuthorAffiliation_xml – name: Materials Science Institute
– name: Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), Facultad de Farmacia y Bioquímica, Consejo Nacional de Investigaciones, Científicas y Técnicas (CONICET)
– name: Lancaster University
– name: Department of Engineering, Faculty of Science and Technology
– name: Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences
– name: Department of Chemistry, Faculty of Science and Technology
Author_xml – sequence: 1
  givenname: Mark D.
  orcidid: 0000-0003-2199-6057
  surname: Ashton
  fullname: Ashton, Mark D.
  organization: Department of Chemistry, Faculty of Science and Technology
– sequence: 2
  givenname: Patricia A.
  surname: Cooper
  fullname: Cooper, Patricia A.
  organization: Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences
– sequence: 3
  givenname: Sofia
  surname: Municoy
  fullname: Municoy, Sofia
  organization: Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), Facultad de Farmacia y Bioquímica, Consejo Nacional de Investigaciones, Científicas y Técnicas (CONICET)
– sequence: 4
  givenname: Martin F.
  surname: Desimone
  fullname: Desimone, Martin F.
  organization: Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), Facultad de Farmacia y Bioquímica, Consejo Nacional de Investigaciones, Científicas y Técnicas (CONICET)
– sequence: 5
  givenname: David
  orcidid: 0000-0003-1353-0329
  surname: Cheneler
  fullname: Cheneler, David
  organization: Lancaster University
– sequence: 6
  givenname: Steven D.
  surname: Shnyder
  fullname: Shnyder, Steven D.
  organization: Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences
– sequence: 7
  givenname: John G.
  orcidid: 0000-0003-0655-2167
  surname: Hardy
  fullname: Hardy, John G.
  email: j.g.hardy@lancaster.ac.uk
  organization: Lancaster University
BookMark eNqFkUtLAzEUhYNUtD7-gKsu3UzNczKzEbTWBxR0oeuQJndqJDOpyVTovze1RdCFrm7CPefkkO8IDbrQAUJnBI8JpuRCmzSeu9BqM6YGY0HKPTQkgpYFLzEdfJ1FIWUtD9FRSm8Y45pxcYAOmZC8kpIO0XQSuj4G78GOrl3QpncfMLoBn0dcj16S6xb5uoja6rmH0dSDyfqd7in4dQsxnaD9RvsEp7t5jF5up8-T-2L2ePcwuZoVmgvSF7wxIBsqZQMUSl3x2hrBwDbUEMxqkKyWtWCk1NaUsuJWiIZZaTjDFusG2DG63OYuV_MWrIHcXXu1jK7Vca2CdurnpnOvahE-VJ0fFRXNAee7gBjeV5B61bpkwHvdQVglRSWpqOSUs_-lZZVLU4E3qXQrNTGkFKH5bkSw2qBSGZXaolI7VNlU_TIZ1-vebXho5_-2jrfWze4trGKXP_0vwydSFq5L
CitedBy_id crossref_primary_10_1002_slct_202301868
crossref_primary_10_1016_j_ijpharm_2024_124701
crossref_primary_10_1002_adma_202211273
crossref_primary_10_1016_j_matchemphys_2023_128545
crossref_primary_10_3390_pharmaceutics15122743
crossref_primary_10_3390_polym14224953
crossref_primary_10_1016_j_mtcomm_2024_108563
Cites_doi 10.1016/j.jconrel.2015.05.266
10.1595/205651319X15585277727868
10.1016/S0021-9258(18)63087-X
10.1002/mabi.201400020
10.1016/j.yrtph.2015.12.006
10.3390/antibiotics10111420
10.1002/j.1875-9114.1982.tb03212.x
10.1016/j.yrtph.2018.11.001
10.1021/acsami.1c25179
10.1039/C5TB00757G
10.1163/156856209X434647
10.1002/pen.760220402
10.1016/j.jconrel.2017.05.028
10.1039/C5RA01851J
10.1038/sj.bjc.6605642
10.1021/acs.molpharmaceut.6b00015
10.1039/c2ra20451g
10.1021/acs.chemmater.9b01798
10.1016/j.progpolymsci.2019.05.002
10.1002/mds3.10141
10.1002/pi.6017
10.1021/acs.biomac.1c01436.s001
10.1002/mabi.201500171
10.1002/admt.202100055
10.1016/j.progpolymsci.2013.06.003
10.1021/la500033b
10.1021/acsmacrolett.0c00488
10.1039/C4RA16103C
10.1016/j.jconrel.2014.03.053
10.1039/C5TB00106D
10.1046/j.1471-4159.1997.69020581.x
10.1039/C6PY01455K
10.1002/pi.5997
10.1021/acsmacrolett.1c00643
10.1021/jacs.5b09974
10.1016/j.jtice.2015.01.003
10.1002/jbm.a.34869
10.1021/am501754s
10.1016/j.cej.2019.01.028
10.1016/j.jconrel.2010.03.023
10.1016/j.addr.2008.02.008
10.1039/C4CS00133H
10.1021/ja00334a076
10.1073/pnas.61.2.748
10.1088/1748-6041/3/3/034108
10.1021/acsabm.1c00699
10.2147/IJN.S94777
10.1002/app.50330
10.1016/j.jconrel.2010.07.122
10.1039/C4RA02861A
10.1159/000350847
10.1038/s41598-018-22066-6
10.1016/j.ccr.2016.04.004
10.1016/0041-008X(79)90270-9
10.1002/adhm.201900622
10.1021/acsbiomaterials.1c01305
10.1002/pi.6089
10.1016/j.copbio.2013.03.011
10.1002/pi.6384
10.1016/j.biomaterials.2006.11.026
10.1016/j.ijpharm.2009.07.033
10.1039/C3CS60235D
10.4236/snl.2012.23009
10.7150/thno.63481
10.1063/1.5138587
10.1021/cm2031569
10.1021/acs.molpharmaceut.5b00697
10.1016/j.nano.2011.08.012
10.1002/macp.201500047
10.1039/C4TB00355A
10.1002/pi.5756
10.1016/j.addr.2007.07.001
10.1021/acsapm.8b00100
10.1016/j.addr.2013.05.010
10.1039/c2tx20035j
10.1002/pi.4908
10.1016/j.addr.2020.09.011
10.1002/adhm.202001876
10.1016/0006-291X(79)92046-1
10.1007/BF03028642
10.1016/j.colsurfb.2018.05.015
10.1039/D1TC03600A
ContentType Journal Article
Copyright 2022 The Authors. Published by American Chemical Society
2022 The Authors. Published by American Chemical Society 2022 The Authors
Copyright_xml – notice: 2022 The Authors. Published by American Chemical Society
– notice: 2022 The Authors. Published by American Chemical Society 2022 The Authors
DBID AAYXX
CITATION
7X8
7S9
L.6
5PM
DOI 10.1021/acs.biomac.2c00516
DatabaseName CrossRef
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA
MEDLINE - Academic


DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1526-4602
EndPage 3040
ExternalDocumentID PMC9277582
10_1021_acs_biomac_2c00516
a161680915
GrantInformation_xml – fundername: ;
  grantid: A103355
– fundername: ;
  grantid: EP/R003823/1
– fundername: ;
  grantid: RG160449
– fundername: ;
  grantid: EP/R512564/1/2065445
GroupedDBID -
02
23N
4.4
55A
5GY
5VS
7~N
AABXI
ABFLS
ABFRP
ABMVS
ABPTK
ABUCX
ACGFS
ACS
AEESW
AENEX
AFEFF
AHGAQ
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
CS3
DU5
EBS
ED
F5P
GGK
GNL
IH9
JG
P2P
RNS
ROL
TN5
UI2
VF5
VG9
W1F
X
XKZ
ZCA
---
-~X
53G
AAHBH
AAYXX
ABBLG
ABJNI
ABLBI
ABQRX
ADHLV
BAANH
CITATION
CUPRZ
ED~
JG~
~02
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-a451t-4fce7f277fe2e6a849dc53edf2c1039e739795316adc6784d55f3d7c430d0afe3
IEDL.DBID ACS
ISSN 1525-7797
1526-4602
IngestDate Thu Aug 21 18:43:09 EDT 2025
Thu Jul 10 19:34:13 EDT 2025
Fri Jul 11 11:01:26 EDT 2025
Tue Jul 01 04:08:17 EDT 2025
Thu Apr 24 23:06:55 EDT 2025
Tue Jul 12 03:10:57 EDT 2022
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
License https://creativecommons.org/licenses/by/4.0
Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a451t-4fce7f277fe2e6a849dc53edf2c1039e739795316adc6784d55f3d7c430d0afe3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-1353-0329
0000-0003-0655-2167
0000-0003-2199-6057
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC9277582
PMID 35748772
PQID 2681032502
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9277582
proquest_miscellaneous_2718274243
proquest_miscellaneous_2681032502
crossref_primary_10_1021_acs_biomac_2c00516
crossref_citationtrail_10_1021_acs_biomac_2c00516
acs_journals_10_1021_acs_biomac_2c00516
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-07-11
PublicationDateYYYYMMDD 2022-07-11
PublicationDate_xml – month: 07
  year: 2022
  text: 2022-07-11
  day: 11
PublicationDecade 2020
PublicationTitle Biomacromolecules
PublicationTitleAlternate Biomacromolecules
PublicationYear 2022
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References ref9/cit9
ref45/cit45
ref3/cit3
ref27/cit27
ref81/cit81
ref63/cit63
ref56/cit56
Shefrin A. E. (ref60/cit60) 2009; 55
ref16/cit16
ref52/cit52
ref23/cit23
ref8/cit8
ref31/cit31
ref59/cit59
ref85/cit85
ref2/cit2
ref77/cit77
ref34/cit34
ref71/cit71
ref37/cit37
ref20/cit20
ref48/cit48
ref74/cit74
ref17/cit17
ref82/cit82
ref10/cit10
ref35/cit35
ref53/cit53
ref19/cit19
ref21/cit21
ref42/cit42
Casado N. (ref68/cit68) 2021; 21
ref46/cit46
ref49/cit49
ref13/cit13
ref61/cit61
ref67/cit67
ref24/cit24
ref38/cit38
ref50/cit50
ref64/cit64
ref78/cit78
ref54/cit54
ref6/cit6
ref36/cit36
ref18/cit18
ref83/cit83
ref65/cit65
ref79/cit79
ref11/cit11
ref25/cit25
ref29/cit29
ref72/cit72
ref76/cit76
ref86/cit86
ref32/cit32
ref39/cit39
ref14/cit14
ref5/cit5
ref51/cit51
ref43/cit43
ref80/cit80
ref28/cit28
ref40/cit40
Tenhunen R. (ref57/cit57) 1976; 8
ref26/cit26
Zimmerman H. J. (ref75/cit75) 1999
ref55/cit55
ref73/cit73
ref69/cit69
ref12/cit12
ref15/cit15
ref62/cit62
ref66/cit66
ref41/cit41
ref58/cit58
ref22/cit22
ref33/cit33
ref4/cit4
ref30/cit30
ref47/cit47
ref84/cit84
ref1/cit1
ref44/cit44
ref70/cit70
ref7/cit7
References_xml – ident: ref39/cit39
  doi: 10.1016/j.jconrel.2015.05.266
– ident: ref35/cit35
  doi: 10.1595/205651319X15585277727868
– ident: ref64/cit64
  doi: 10.1016/S0021-9258(18)63087-X
– ident: ref80/cit80
  doi: 10.1002/mabi.201400020
– ident: ref72/cit72
  doi: 10.1016/j.yrtph.2015.12.006
– ident: ref62/cit62
  doi: 10.3390/antibiotics10111420
– ident: ref76/cit76
  doi: 10.1002/j.1875-9114.1982.tb03212.x
– ident: ref71/cit71
  doi: 10.1016/j.yrtph.2018.11.001
– ident: ref13/cit13
  doi: 10.1021/acsami.1c25179
– ident: ref14/cit14
  doi: 10.1039/C5TB00757G
– ident: ref23/cit23
  doi: 10.1163/156856209X434647
– ident: ref66/cit66
  doi: 10.1002/pen.760220402
– ident: ref78/cit78
  doi: 10.1016/j.jconrel.2017.05.028
– ident: ref69/cit69
  doi: 10.1039/C5RA01851J
– ident: ref86/cit86
  doi: 10.1038/sj.bjc.6605642
– ident: ref3/cit3
  doi: 10.1021/acs.molpharmaceut.6b00015
– ident: ref5/cit5
  doi: 10.1039/c2ra20451g
– ident: ref6/cit6
  doi: 10.1021/acs.chemmater.9b01798
– ident: ref45/cit45
  doi: 10.1016/j.progpolymsci.2019.05.002
– ident: ref33/cit33
  doi: 10.1002/mds3.10141
– ident: ref47/cit47
  doi: 10.1002/pi.6017
– ident: ref70/cit70
  doi: 10.1021/acs.biomac.1c01436.s001
– ident: ref82/cit82
  doi: 10.1002/mabi.201500171
– ident: ref31/cit31
  doi: 10.1002/admt.202100055
– ident: ref10/cit10
  doi: 10.1016/j.progpolymsci.2013.06.003
– ident: ref40/cit40
  doi: 10.1021/la500033b
– ident: ref8/cit8
  doi: 10.1021/acsmacrolett.0c00488
– ident: ref18/cit18
  doi: 10.1039/C4RA16103C
– ident: ref85/cit85
  doi: 10.1016/j.jconrel.2014.03.053
– ident: ref41/cit41
  doi: 10.1039/C5TB00106D
– ident: ref79/cit79
  doi: 10.1046/j.1471-4159.1997.69020581.x
– ident: ref16/cit16
  doi: 10.1039/C6PY01455K
– ident: ref48/cit48
  doi: 10.1002/pi.5997
– ident: ref7/cit7
  doi: 10.1021/acsmacrolett.1c00643
– ident: ref2/cit2
  doi: 10.1021/jacs.5b09974
– ident: ref51/cit51
  doi: 10.1016/j.jtice.2015.01.003
– ident: ref11/cit11
  doi: 10.1002/jbm.a.34869
– ident: ref9/cit9
  doi: 10.1021/am501754s
– ident: ref32/cit32
  doi: 10.1016/j.cej.2019.01.028
– ident: ref25/cit25
  doi: 10.1016/j.jconrel.2010.03.023
– ident: ref54/cit54
  doi: 10.1016/j.addr.2008.02.008
– ident: ref1/cit1
  doi: 10.1039/C4CS00133H
– ident: ref22/cit22
  doi: 10.1021/ja00334a076
– ident: ref58/cit58
  doi: 10.1073/pnas.61.2.748
– ident: ref55/cit55
  doi: 10.1088/1748-6041/3/3/034108
– ident: ref15/cit15
  doi: 10.1021/acsabm.1c00699
– ident: ref42/cit42
  doi: 10.2147/IJN.S94777
– ident: ref61/cit61
  doi: 10.1002/app.50330
– ident: ref84/cit84
  doi: 10.1016/j.jconrel.2010.07.122
– ident: ref20/cit20
  doi: 10.1039/C4RA02861A
– ident: ref59/cit59
  doi: 10.1159/000350847
– ident: ref81/cit81
  doi: 10.1038/s41598-018-22066-6
– ident: ref12/cit12
  doi: 10.1016/j.ccr.2016.04.004
– volume: 55
  start-page: 704
  year: 2009
  ident: ref60/cit60
  publication-title: Can. Fam. Physician
– ident: ref74/cit74
  doi: 10.1016/0041-008X(79)90270-9
– ident: ref36/cit36
  doi: 10.1002/adhm.201900622
– ident: ref26/cit26
  doi: 10.1021/acsbiomaterials.1c01305
– ident: ref38/cit38
  doi: 10.1002/pi.6089
– ident: ref34/cit34
  doi: 10.1016/j.copbio.2013.03.011
– ident: ref46/cit46
  doi: 10.1002/pi.6384
– ident: ref24/cit24
  doi: 10.1016/j.biomaterials.2006.11.026
– ident: ref52/cit52
  doi: 10.1016/j.ijpharm.2009.07.033
– ident: ref30/cit30
  doi: 10.1039/C3CS60235D
– ident: ref67/cit67
  doi: 10.4236/snl.2012.23009
– ident: ref43/cit43
  doi: 10.7150/thno.63481
– ident: ref37/cit37
  doi: 10.1063/1.5138587
– ident: ref4/cit4
  doi: 10.1021/cm2031569
– ident: ref21/cit21
  doi: 10.1021/acs.molpharmaceut.5b00697
– ident: ref77/cit77
  doi: 10.1016/j.nano.2011.08.012
– ident: ref53/cit53
  doi: 10.1002/macp.201500047
– volume: 8
  start-page: 2
  year: 1976
  ident: ref57/cit57
  publication-title: Ann. Clin. Res.
– ident: ref29/cit29
  doi: 10.1039/C4TB00355A
– ident: ref49/cit49
  doi: 10.1002/pi.5756
– ident: ref83/cit83
  doi: 10.1016/j.addr.2007.07.001
– ident: ref17/cit17
  doi: 10.1021/acsapm.8b00100
– ident: ref19/cit19
  doi: 10.1016/j.addr.2013.05.010
– ident: ref44/cit44
  doi: 10.1039/c2tx20035j
– ident: ref50/cit50
  doi: 10.1002/pi.4908
– volume: 21
  start-page: 1
  volume-title: RSC Polymer Chemistry Series
  year: 2021
  ident: ref68/cit68
– ident: ref27/cit27
  doi: 10.1016/j.addr.2020.09.011
– ident: ref73/cit73
  doi: 10.1002/adhm.202001876
– ident: ref56/cit56
  doi: 10.1016/0006-291X(79)92046-1
– ident: ref65/cit65
  doi: 10.1007/BF03028642
– ident: ref63/cit63
  doi: 10.1016/j.colsurfb.2018.05.015
– volume-title: Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver
  year: 1999
  ident: ref75/cit75
– ident: ref28/cit28
  doi: 10.1039/D1TC03600A
SSID ssj0009345
Score 2.4369276
Snippet Biomaterials capable of precisely controlling the delivery of agrochemicals/biologics/drugs/fragrances have significant markets in the agriscience/healthcare...
Biomaterials capable of precisely controlling the delivery of agrochemicals/biologics/drugs/fragrances have significant markets in the agriscience/healthcare...
SourceID pubmedcentral
proquest
crossref
acs
SourceType Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 3031
SubjectTerms agrochemicals
bilirubin
biocompatible materials
composite polymers
computer simulation
dexamethasone
health services
phosphates
pyrroles
Title Controlled Bioactive Delivery Using Degradable Electroactive Polymers
URI http://dx.doi.org/10.1021/acs.biomac.2c00516
https://www.proquest.com/docview/2681032502
https://www.proquest.com/docview/2718274243
https://pubmed.ncbi.nlm.nih.gov/PMC9277582
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT8MwDLbGOMCFN2K8VCQkDtCxpknTHcfYNCENIcEkblWaB0xMHdrjMH49cdttTMC0Y1snVR27dmL7M8AlIyq2gkRcLYzdoBAeuLEKmUsMV1RSRkRaKNx-DFod-vDKXgtw808En3i3Qg7LWIpupycSZShYg3UShBy3WrX68xxi109bEmNDH-szVnleIvP3HGiM5HDRGM09zMX8yB8Gp7kN7WnZTpZn8lEej-Ky_PqN4rjSt-zAVu55OrVMVHahoJM92KhPG77tQ6Oepa33tHLuun2R_gmde93D1I2JkyYX2Mu3gVBYb-U0sg46Od1TvzfBM_AD6DQbL_WWm3dZcAVl3silRmpuCOdGEx2IkFaVZL5WhkgME2uOkT-rqYFQ0lo2qhgzvuKS-hVVEUb7h1BM-ok-AocFxo81Vyz2FEXcmbBirImUQhhDTShKcGU5EOVaMozSADjxIryZsSXK2VICb7owkczByrFnRm_pmOvZmM8MqmMp9cV0vSPLZwyTiET3x8OIIESbb11DsoTGmnQMclO_BHxBWGavRtzuxSdJ9z3F765aZrOQHK_MjRPYJFh1gXie3ikUR4OxPrO-0Cg-T1XgG1CLCGg
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwzV1Lb9NAEB6VcigX3ojwNBKIA3KJx7te58ChpKlS-hASrdSbWe8DKiIH1YlQ-Dv8FX4YM2snIQhFXCpxtL0Pe3Z291vPzDcAzyXakhQJY6c9HVBQZXFpcxmjV1YYIVGHQOGj42x4Kt6dybMN-DGPhaGXqKmlOhjxl-wCyWu-xxHp1AsaVqWs9aQ8cLNvdE6r3-zv0qC-QNwbnPSHcZtKINZCJpNYeOOUR6W8Q5fpXPSskamzHg3bQp1i8xapY6atoeVbWCl9apURadd2tXcptXsFrhL6QT7h7fQ_LJl905AJmfMIEVTtqTYy5-_vzHugqVf3wCWwXXXL_G2f27sBPxcSCu4tX7ank3LbfP-DPPI_F-FNuN7i7GinmRi3YMNVt2GrP09vdwcG_cZJf-Rs9PZ8rMO6H-26ETuqzKLgSkGXny605eiyaNDkC2rLvR-PZvzH_y6cXspX3IPNaly5-xDJzKelU1aWiRXMspN3PQECo7X3wue6Ay9J4kW7JtRFMPdjUvDNZhiKdhg6kMz1oTAtNTtnCBmtrfNqUedrQ0yytvSzuZoVJGc2CunKjad1gUxIlxIQxjVlCMCwSV-kHVArOrromlnKV59U558DW3mPhC1zfPDP0ngKW8OTo8PicP_44CFcQ443YSbT5BFsTi6m7jGhwEn5JMzCCD5ets7-AtRObBI
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VIgGXlqdYaCFIIA4oZePYcfbQQ7sPtRSqSlCpt9TxAypW2arZVbX8If4KP6szjnfLIrTi0gPHOH5lPLZnMjPfALwWzJTISCy2yqGCwmQWlyYXMXPScM0FUz5Q-NNhtnfMP5yIkxX4OYuFwUnU2FPtjfi0q8-NCwgDyXsqp6h0HIlpYqcseFMe2Okl6mr19n4PF_YNY4P-l-5eHNIJxIqLZBxzp610TEpnmc1UzjtGi9QaxzTZQ60kExeyZKaMxiOcGyFcaqTmadu0lbMp9nsLbpOdkLS8ne7na3Tf1GdDplxCKK52ZIjO-fuc6R7U9eI9eC3cLrpm_nbXDdbh15xK3sXl-9ZkXG7pH38ASP4HZLwPa0HejnaaDfIAVmz1EO52Z2nuHkG_2zjrD62Jds9Gyp__Uc8OyWFlGnmXCnz8eqEMRZlF_SZvUKh3NBpO6c__Yzi-ka94AqvVqLJPIRKZS0srjSgTwwltJ287FAy0Us5xl6sWvEWKF-FsqAtv9mdJQYXNMhRhGVqQzHii0AGinTKFDJe2eTdvc94AlCyt_WrGagXSmYxDqrKjSV0wAqZLUSBmS-qgIEOmfZ62QC7w6XxoQitffFOdffOo5R0ktsjZs3-mxku4c9QbFB_3Dw-ewz1GYScEaJpswOr4YmI3URgcly_8Rozg9KZZ9gqcXG6V
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Controlled+Bioactive+Delivery+Using+Degradable+Electroactive+Polymers&rft.jtitle=Biomacromolecules&rft.au=Ashton%2C+Mark+D&rft.au=Cooper%2C+Patricia+A&rft.au=Municoy%2C+Sofia&rft.au=Desimone%2C+Martin+F&rft.date=2022-07-11&rft.issn=1526-4602&rft.volume=23&rft.issue=7+p.3031-3040&rft.spage=3031&rft.epage=3040&rft_id=info:doi/10.1021%2Facs.biomac.2c00516&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1525-7797&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1525-7797&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1525-7797&client=summon